Radiant Business Consortium Limited

Importer and Distributor of Innovative Pharmaceutical Solutions in Bangladesh

Representing Leading Global Brands Across the Specialty & Diagnostics Segment

F. Hoffmann-La Roche Ltd, Switzerland
Cheplapharm, Switzerland
Cheplapharm, Germany
Abbott Molecular Diagnostics, Germany
Tosoh, Japan

Our values

About Radiant Business Consortium Limited

Radiant Business Consortium Limited (RBCL) is a private limited company established in July 2004, and is a leading pharmaceutical importer, distributor, and promoter in Bangladesh. Since 2005, RBCL is serving as the exclusive importer and authorized agent for the pharmaceutical division of F. Hoffmann-La Roche Ltd., Switzerland, while also maintaining strategic partnerships with other globally recognized pharmaceutical and diagnostics companies, including Cheplapharm (Switzerland & Germany), Abbott Molecular Diagnostics (Germany), and Tosoh (Japan). Through these collaborations, RBCL facilitates access to essential therapies encompassing oncology, hepatology, advanced biotechnology products, and specialized diagnostic solutions.

Business Consortium Logo

Radiant Business Consortium Limited

Partners

Our Global Partners

RBCL partners with leading global pharmaceutical suppliers to deliver high-quality, life-saving medicines. Our trusted collaborations ensure safety, reliability, and international standards across Bangladesh.

F. Hoffmann-La Roche Ltd. Switzerland

Cheplapharm Switzerland

Cheplapharm Germany

Abbott`s Molecular Diagnostics Germany

Newsroom

News & Insights

Discover the latest news and insights about our achievements and Contributions

Radiant Affiliate Companies

Strength in collaboration,
synergy in action

Explore and discover Radiant's collaborative ecosystem

Contact Us

We are here to answer all your concerns

CHQ Phone Number

+88 029 835717 (Tel)
+88 025 5058522 (Fax)

CHQ Address:

SKS Tower (7th Floor), 7 VIP Road, Mohakhali, Dhaka 1206, Bangladesh

Confidentiality Note:

Any information related to the identities of the patient and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.

AcceptDecline